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2. METHODS AND MATERIALS
SAMPLE EXTRACTION
Based upon previous 
research indicating that 
miRNA is still present in 
DNA extract all samples 
under went solid phase 
DNA extraction.6
cDNA  SYNTHESIS
All  blood, saliva, 
vaginal material and 
seminal fluid extracts 
underwent stem-loop 
reverse transcription 7
PCR
cDNA products from all 
body fluids underwent PCR 
using labelled microRNA 
markers. DNA amplification 
was performed only on 
saliva. 
CE
All PCR products were 
diluted  a 100-fold and 
STR and miR analysis 
was carried out using 
a 3130  genetic 
analyzer.
SAMPLE RECOVERY
Blood, saliva, seminal 
fluid and vaginal 
material were 
recovered from 
volunteers with 
informed consent.  
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MicroRNA (miRNA) are small interfering molecules that have a role in the negative regulation of protein expression. These molecules are thought to be more stable than messenger RNA
due to their short size and relative abundance within the cell.1,2 In addition, miRNA is thought to be immune from the effect of ribonuclease activity. These characteristics, along with its
tissue specific expression, make the molecules a superior candidate for body fluid identification. Current efforts in body fluid identification focus on developing a process where RNA and
DNA are separately analysed, requiring two sets of resources.3,4 This project seeks to enhance STR analysis by incorporating body fluid specific microRNA primers within the STR PCR mix.5
Proof of principle has already been demonstrated by van der Meer et al.5 The aim of this study is to expand the number of body fluid specific markers and to evaluate them in context of
STR analysis
3. CAPILLARY ELECTROPHORETIC ANALYSIS OF MICRORNA
1. INTRODUCTION
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4. CE OF DNA AND MIR
hsa-miR-205
51.89 bp
miRNA amplicon 51.89 bp
The EPG above was produced
following 29 PCR cycles
amplification of hsa-miR-205 in a
saliva sample whilst multiplexed
VAGINAL MATERIAL
hsa-miR-203 64.31 bp ±1.35
hsa-miR-205 61.77 bp ±0.99
hsa-miR-224 60.23 bp ±0.21
mmu-miR-451 54.44 bp ±0.35
hsa-miR-891a 61.78 bp ±1.53
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BLOOD
hsa-miR-203 46.78 bp ± 0.09
hsa-miR-205 No Expression
hsa-miR-224 58.75 bp ± 0.40
mmu-miR-451 59.52 bp ± 0.55
hsa-miR-891a 58.30 bp ± 0.23
SALIVA
hsa-miR-203 46.99 bp ±0.18
hsa-miR-205 48.13 bp ±0.06
hsa-miR-224 54.03 bp ±0.38 
mmu-miR-451 No Expression
hsa-miR-891a No Expression
SEMINAL FLUID
hsa-miR-203 62.35bp ±0.88 
hsa-miR-205 59.65 bp ±0.39 
hsa-miR-224 60.73 bp ±0.84 
mmu-miR-451 60.38 bp ±1.46 
hsa-miR-891a 59.44 bp ±0.42 
7. DISCUSSION
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The results in Section 3 are the EPGs associated with the body fluids where the indicated markers were targeted and amplified prior to fragment
analysis. The amplicons highlighted in blue demonstrates the base pair sizes, typically between 45 to 65 bp in length. Since the targeted markers
amplify to create products of differing base pair lengths for each body fluid and shows little variation between individuals, CE could be used to
differentiate between types of body fluid. The peaks visible before the microRNA peak are usually half the size and can be identified as primer
dimers. There are some indications of cross-reactivity as demonstrated by similar peaks in different body fluids; however, this is expected given
that 40 PCR cycles was used to amplify them along with relatively high primer concentrations.
The aim of this study was to assess whether or not CE could be used to characterise miRNA markers with a view to differentiating between body fluids. This was explored by 
extracting samples from a range of body fluids. These then underwent cDNA synthesis before undergoing qPCR. Fourteen body fluid specific miRNA markers were targeted 
and five markers were subsequently selected for CE and presented above. 
The results presented in Section 3 indicated that miRNA markers could be detected and that individual markers can be expressed differently in various body fluids. Thus CE 
has the potential for characterising miRNA markers sufficiently for BFID. There are indications of over-amplification; which is to be expected given that qPCR was carried out 
using 40 PCR cycles. Section 4 demonstrates that 29 PCR cycles is still sufficient for analysis. This section also demonstrates that such miRNA markers can be characterised 
alongside STR markers thus enhancing the information that can be gathered from a DNA profile
with the NGM SE Kit (Life
Technologies). This result
demonstrated that miRNA can still
be characterised following 29 PCR
cycles. This result also
demonstrated that microRNA
probes can be incorporated into
the STR kit to simultaneously
produce both a reportable DNA
profile and a body fluid specific
miRNA profile. Optimisation of
stem-loop RT primers and PCR
primers is yet to be completed.
The inclusion of the DNA profile
highlights one of the major
advantages of targeting miRNA
markers for body fluid
identification in that the
amplicons do not appear to
interfere with any of the STR
markers.
